July 27, 2021
As cited by the research report titled ‘Growth Hormone Market Size By Product (Powder, Solvent), By Application, By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Medstores), Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027’, available with Market Study Report, global growth hormone market is projected to expand significantly over 2021-2027.
Rising incidences of hormonal disorders in individuals, coupled with increasing regulatory approvals for growth hormone therapy are primarily driving the global growth hormone market growth. Additionally, inclination towards this therapy for treating small for gestational age (SGA) condition and other disorders is augmenting the market outlook.
Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/3793253/
Recent studies suggest that getting infected with Covid-19 during pregnancy can result in preterm delivery, with over 15.5% cases of small for gestational age (SGA). In some cases, infants with SGA may also acquire a transient bullous eruption. Another research has found that there is a higher risk of the SARS-CoV-2 infection with serious prognosis in older obese male population with insufficient secretion of growth hormone (GH). Such statistics point towards importance of growth hormones.
Based on product type, worldwide growth hormone industry is segmented into powder, and solvent. Among these, solvent segment is anticipated to grow at 8% CAGR over the analysis period, on account of increasing distribution of drugs worldwide.
Speaking of application ambit, the marketplace is divided into growth hormone deficiency, idiopathic short stature, small for gestational age, turner syndrome, and prader-willi syndrome among others. As cited in the report, small for gestational age segment accounted for USD 214 million valuation in 2020, due to increased usage of hormonal therapy for the disease.
Considering the distribution channels, the business space is categorized into online medstores, hospital pharmacy, and retail pharmacy. Among these, hospital pharmacy segment held over 55% market share in 2020, credited to large number of hospital visits, and increased prescription rate.
The geographical analysis of this industry extends to North America, Middle East & Africa, Asia-Pacific, Europe, and Latin America. The report cites that Latin America market is anticipated to record a 6% CAGR over 2021-2027, on account of rising awareness regarding growth disorders and their treatment options.
Prominent players influencing the worldwide growth hormone industry dynamics are Genentech Inc., Ferring B.V., LG Chem Ltd., Anhui Anke Biotechnology (Group) Co. Ltd., Ipsen S.A., Merck KGaA, Eli Lilly and Company, Novartis AG, Pfizer Inc., and Novo Nordisk A/S.